Involvement of the periaqueductal grey matter and spinal 5-hydroxytryptaminergic pathways in morphine analgesia: effcts of lesions and 5-hydroxytryptamine depletion.
about
Single-walled carbon nanotubes chemically functionalized with polyethylene glycol promote tissue repair in a rat model of spinal cord injuryEntanglement between thermoregulation and nociception in the rat: the case of morphine.Spinal Serotonergic and Opioid Receptors Are Involved in Electroacupuncture-Induced Antinociception at Different Frequencies on ZuSanLi (ST 36) Acupoint.Loss of dopamine D1 receptors and diminished D1/5 receptor-mediated ERK phosphorylation in the periaqueductal gray after spinal cord lesion.On the role of 5-hydroxytryptamine in drug-induced antinociception.Muscimol injections in the nucleus raphé dorsalis block the antinociceptive effect of morphine in rats: apparent lack of 5-hydroxytryptamine involvement in muscimol's effect.Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.Effects of two N-arylpiperazinylmethylpyrazolo [1,5-d][1,2,4]triazine derivatives in pain and antidepressant tests in mice.Mu- and delta-opioid receptor mRNAs are expressed in spinally projecting serotonergic and nonserotonergic neurons of the rostral ventromedial medulla.Pirenperone does not attenuate morphine analgesia in spinal rats.A neuroanatomical framework for the central modulation of respiratory sensory processing and cough by the periaqueductal grey.Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy-induced neuropathic pain.A mesolimbic neuronal loop of analgesia: I. Activation by morphine of a serotonergic pathway from periaqueductal gray to nucleus accumbens.Regular physical activity prevents development of chronic muscle pain through modulation of supraspinal opioid and serotonergic mechanisms.Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs).
P2860
Q24626465-53AEA72A-457A-4C85-820B-753731E3C36AQ36125961-75C9064B-8F10-4854-B77F-0DBA646886BBQ36763451-F8F6160E-E60E-48CE-BD7A-0E02C44FBC6DQ37603968-68F52842-ED04-4799-8AC7-65C24F855F74Q40066941-613235D2-7422-44C7-8DF9-F7AE91EF55C2Q41744930-ADCD9C47-A78F-4287-B1CF-66BA33D54FEBQ42506514-E450C808-673E-419C-A8BC-83EE350E1DC6Q42546648-272BF6DB-02CA-460B-82F9-1252823033B3Q44351252-BC1EBCFB-1CFB-4B7D-AE04-73809F5385F8Q44729117-9EEAFC37-3926-47EA-92ED-E2A1FDE825A7Q47149338-4545E702-76D7-4944-ABEA-1EB16D56FCB2Q48250330-11FBA17F-4957-412E-8062-F723B0993338Q48372517-1FE4D8DE-4597-4648-BF0B-1C6278AF8299Q49384590-46DF50CC-48B6-44AE-9A28-3F80FB1E3553Q55421497-74F44AE0-FE5D-49E6-84C5-01C4597BD36E
P2860
Involvement of the periaqueductal grey matter and spinal 5-hydroxytryptaminergic pathways in morphine analgesia: effcts of lesions and 5-hydroxytryptamine depletion.
description
1978 nî lūn-bûn
@nan
1978 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Involvement of the periaqueduc ...... 5-hydroxytryptamine depletion.
@ast
Involvement of the periaqueduc ...... 5-hydroxytryptamine depletion.
@en
type
label
Involvement of the periaqueduc ...... 5-hydroxytryptamine depletion.
@ast
Involvement of the periaqueduc ...... 5-hydroxytryptamine depletion.
@en
prefLabel
Involvement of the periaqueduc ...... 5-hydroxytryptamine depletion.
@ast
Involvement of the periaqueduc ...... 5-hydroxytryptamine depletion.
@en
P2860
P1476
Involvement of the periaqueduc ...... 5-hydroxytryptamine depletion.
@en
P2093
Dostrovsky JO
P2860
P304
P356
10.1111/J.1476-5381.1978.TB07785.X
P407
P577
1978-05-01T00:00:00Z